Home/Filings/4/0000950170-24-091156
4//SEC Filing

KURIYEL RALF 4

Accession 0000950170-24-091156

CIK 0000730272other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 9:56 PM ET

Size

15.8 KB

Accession

0000950170-24-091156

Insider Transaction Report

Form 4
Period: 2024-08-02
KURIYEL RALF
Senior VP, R&D
Transactions
  • Sale

    Common Stock

    2024-08-02$159.36/sh6,973$1,111,21712,288 total
  • Exercise/Conversion

    Common Stock

    2024-08-02$86.10/sh+175$15,06712,463 total
  • Sale

    Common Stock

    2024-08-02$158.85/sh175$27,79912,288 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-08-02+1750 total
    Exercise: $86.10Exp: 2030-02-27Common Stock (175 underlying)
Footnotes (1)
  • [F1]This option is fully vested and exercisable. Exhibit 24.1: Power of Attorney

Issuer

REPLIGEN CORP

CIK 0000730272

Entity typeother

Related Parties

1
  • filerCIK 0001733143

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 9:56 PM ET
Size
15.8 KB